Volume 57 - Issue 5 - May 2011

A Checklist for Quality and Progress

  At the recent Ostomy Wound Management Editorial Board meeting, held yearly at the Spring Symposium on Advanced Wound Care, participants were asked to suggest new ongoing print and online columns that would address key issues in health- and wound care. Board members — clinicians, educators, and administrators, all literally with their fingers on the pulse of what is happening in healthcare — made quick and efficient work of providing numerous ideas that reflect both persistent and emerging concerns. With sincere gratitude to the OWM Board and in no particular order:



Pearls for Practice: Preventing Stage I Pressure Ulcers

Pearls for Practice is made possible through the support of Ferris Mfg. Corp, Burr Ridge, IL (www.polymem.com). The opinions and statements of the clinicians providing Pearls for Practice are specific to the respective authors and are not necessarily those of Ferris Mfg. Corp., OWM, or HMP Communications. This article was not subject to the Ostomy Wound Management peer-review process.



Nutrition 411: The Use of Cranberry Products for Urinary Tract Infection Prevention

  Urinary tract infections (UTIs) are the most prevalent infection in long-term care (LTC), accounting for at least 40% of all infections and more than 8% of total nursing home costs.1,2 UTIs are the most prevalent source of bacteremia, the most common cause for hospital transfers, and the most common condition for which antibiotics are prescribed. Although patients usually respond to antimicrobial treatment, the recurrence rate is high and associated with side effects.



Continence Coach: New Subspecialty Certifies Expertise in Female Pelvic Reconstructive Surgery

  At its March meeting, the American Board of Medical Specialties (ABMS) formally established a new subspecialty: Female Pelvic Medicine and Reconstructive Surgery.1 The new subspecialty will be administered jointly by the American Board of Obstetrics and Gynecology (ABOG) and the American Board of Urology (ABU).



My Scope of Practice: A Champion “Found” by Incontinence Care

If we are facing in the right direction, all we have to do is keep on walking. —Buddhist saying



Incidence of Hospital-Acquired Pressure Ulcers in Acute Care Using Two Different Risk Assessment Scales: Results of a Retrospective Study

Abstract

  More than one million people develop pressure ulcers (PU) every year in the US — a major problem that leads to increased morbidity and mortality. A hospital-acquired PU (HAPU) is defined as any ulcer noted 24 or more hours after hospital admission. The purpose of this retrospective study was to compare the incidence of HAPUs between two 1-year periods of time (March 1, 2007 through March 17, 2008 and March 18, 2008 through March 31, 2009) at an acute care facility. Records from all admitted adult medical-surgical and critical care patients along with routinely submitted quality control reports on patients who acquired PUs during hospitalization were reviewed and abstracted. A locally developed PU risk assessment instrument (SST) was used during the first time period and the Braden Scale (BS) was used during the second time period. The overall PU incidence was 368 in 41,840 patient admissions (8.80 per 1,000); 9.49 in the SST and 8.08 in the BS patient sample (P = 0.125). No significant differences in patient age, race, and PU severity or location were observed. However, the incidence of more severe ulcers (Stage III and Stage IV) was lower in the BS group (0.5667 in the SST group compared to 0.2419 per 1,000 admissions in the BS group) even though median patient length of stay was longer (28 days and 34 days in the SST and BS groups, respectively), suggesting that use of a valid and reliable PU risk assessment instrument may reduce the incidence of severe PUs. Study design and sample size limit the ability to generalize the results of this study. Controlled clinical studies comparing the effect of different PU risk assessment instruments on PU incidence are needed.

Key Words: retrospective study, comparison, pressure ulcer, risk assessment, Braden Scale

Index: Ostomy Wound Management 2011;57(5):20–27

Potential Conflicts of Interest: none disclosed



Using Chamomile Solution or a 1% Topical Hydrocortisone Ointment in the Management of Peristomal Skin Lesions in Colostomy Patients: Results of a Controlled Clinical Study

Abstract

  Peristomal skin complications interfere with stoma appliance use and negatively affect patient quality of life. To find an alternative to long-term peristomal skin treatment involving corticosteroid products, a prospective study was conducted to compare the effect of a German chamomile solution to topical steroids on peristomal skin lesions in colostomy patients. Persons seeking care for the treatment of a peristomal skin lesion were assigned to a treatment regimen of once-a-day hydrocortisone 1% ointment (n = 36) or twice-a-day chamomile compress (n = 36) application. Treatments were assigned by matching patient demographic, history, and skin condition variables. At baseline, no significant differences between the variables were observed. Forty-two (42) of the 72 patients were female. Most participants had their stoma for more than 1 year (18.14 months in the chamomile and 17.69 months in the steroid group). Lesions were assessed every 3 days for a maximum of 28 days. Lesions healed significantly faster in the chamomile than in the hydrocortisone group (mean time to healing 8.89 ± 4.89 and 14.53 ± 7.6 days, respectively; P = 0.001). Stoma patient symptoms (pain and itching) also resolved more expediently in the chamomile than in the hydrocortisone group. Because corticosteroids are nonspecific anti-inflammatory agents, herbal extract use can prevent the side effects of long-term topical corticosteroid use. The results of this study suggest that German chamomile can be recommended to relieve itching and inflammation and that twice-daily application facilitates healing of peristomal skin lesions. Methods to facilitate the application of topical treatments without interfering with appliance adhesion or necessitating frequent appliance removal should be refined. Additional randomized studies are needed to confirm the results of this study.

Key Words: peristomal, skin lesions, topical, chamomile, controlled clinical study

Index: Ostomy Wound Management 2011;57(5):28–36

Potential Conflicts of Interest: none disclosed



Adenocarcinoma of a Colostomy Following Abdominoperineal Resection for Squamous Cell Carcinoma of the Anal Canal: A Case Study

Abstract

  Malignant neoplasms presenting on a stoma, as well as the development of colorectal adenocarcinoma after previous treatment for squamous cell carcinoma (SCC) of the anal canal, are rare. The unique case is presented of an 81-year-old woman with parastomal bleeding and ulceration found to have a primary colorectal adenocarcinoma arising de novo on a colostomy, formed after salvage abdominoperineal resection (APR) 3 years earlier for recurrent anal SCC. This is the first reported case of a colonic adenocarcinoma on a colostomy formed after an APR for anal SCC. Although stomal neoplasia is rare, the appearance of a friable bleeding lesion on the stoma should be investigated to exclude metastatic cancer or a second primary malignancy.

Key Words: case study, stoma, colorectal adenocarcinoma, parastomal bleeding

Index: Ostomy Wound Management 2011;57(5):38–40

Potential Conflicts of Interest: none disclosed



May New Products and Industry News

Study shows silver kills MRSA and other antibiotic-resistant infections
  ConvaTec (Skillman, NJ) released new in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of highly resistant bacteria, commonly referred to as superbugs. The study showed that bacteria found beneath the dressing died within 48 hours. The study results were presented at the 24th Annual Symposium on Advanced Wound Care and Wound Healing Society in Dallas, TX.